Key result
Endoluminal techniques like TEVAR effectively manage chronic type B aortic dissection in higher-risk surgical patients.
Why the study?
Recent advances have been made in endovascular devices and techniques for chronic type B aortic dissection, prompting an updated review of their current status.
Endoluminal techniques, including TEVAR and novel false lumen occlusion methods, provide effective treatment options for chronic type B aortic dissection, especially in patients at high surgical risk.
Endovascular advances for cTBAD in high-risk patients support selective use; Level 5 evidence leaves optimal technique and long-term durability open.
In recent guidelines of international societies, the most frequent indication for treatment after chronic type B aortic dissection (cTBAD) is aneurysmal dilatation. Endovascular repair is recommended in patients with moderate to high surgical risk or with contraindications to open repair. During the last decade, many advances have been made in the field of endovascular techniques and devices. The aim of this article is to address the current status of endoluminal techniques for the management of cTBAD including standard thoracic endovascular repair, new devices, fenestrated and branched abdominal aortic devices and false lumen occlusion techniques.
No takes yet. Share an insight, caveat, or question.
Σπανός et al. (2020) conducted a review in Chronic Type B Aortic Dissection. Endoluminal techniques (TEVAR) was evaluated. Endoluminal techniques, including standard thoracic endovascular repair and new devices, provide effective management for chronic type B aortic dissection, particularly in patients with moderate to high surgical risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: